Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT02629796 · clinicaltrials.gov ↗

COMPLETED

Status

44

Enrollment

NETWORK

Sponsor class

Conditions

CIDP

Interventions

OTHER: CIDP treated (IVIG)

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild